Entry Detail



General Information

Database ID:exR0089523
RNA Name:hsa-miR-155-5p
RNA Type:miRNA
Chromosome:chr21
Starnd:+
Coordinate:
Start Site(bp):25573983End Site(bp):25574006
External Links:hsa-miR-155-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
TSC22D4
chr7
100463359
100479232
-
ACOT7
chr1
6264269
6394391
-
MRFAP1
chr4
6640091
6642745
+
SH3KBP1
chrX
19533977
19887600
-
NUFIP2
chr17
29255839
29294148
-
CENPM
chr22
41938737
41947152
-
SP100
chr2
230415942
230545606
+
ARL3
chr10
102673731
102714397
-
JAK1
chr1
64833229
65067754
-
LAPTM4A
chr2
20032650
20051628
-
SOD2
chr6
159669069
159745186
-
HNRNPLL
chr2
38561969
38603586
-
LCP1
chr13
46125920
46211871
-
AICDA
chr12
8602170
8612867
-
CD52
chr1
26317958
26320523
+
MFSD9
chr2
102714630
102736888
-
NDUFA4
chr7
10931943
10940153
-
CHEK2
chr22
28687743
28742422
-
ZMYM5
chr13
19823482
19863649
-
PGLS
chr19
17511636
17521288
+
CCNB1
chr5
69167135
69178245
+
IL2RG
chrX
71107404
71112108
-
CXXC1
chr18
50282343
50288304
-
RBM38
chr20
57391396
57409333
+
CFL1
chr11
65823022
65862026
-
PPM1B
chr2
44167969
44244384
+
ZFP36
chr19
39406847
39409412
+
FTL
chr19
48965309
48966879
+
ERH
chr14
69380128
69398299
-
VPS18
chr15
40894450
40903975
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000642
chr15
80390757
80415142
+
hsa_circ_0000892
chr19
11941431
12014514
+
hsa_circ_0001046
chr2
97024782
97033111
+
hsa_circ_0000643
chr15
80412669
80415142
+
hsa_circ_0000698
chr16
47531309
47549512
+
hsa_circ_0001146
chr20
34241449
34246936
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC021078.1
chr5
149494314
149504670
-
AC090198.1
chr8
124488510
124491643
+
AC245033.4
chr15
82533175
82540008
-
AL022311.1
chr22
37876148
37895563
+
ELOA-AS1
chr1
23706901
23778296
-
GABPB1-AS1
chr15
50354959
50372202
+
LINC00240
chr6
26956932
27059749
+
LINC01772
chr1
16460948
16468481
+
MALAT1
chr11
65497688
65506516
+
MIR155HG
chr21
25561909
25575168
+
MIR17HG
chr13
91347820
91354579
+
NORAD
chr20
36045618
36051018
-
OIP5-AS1
chr15
41283990
41309737
+
SNHG5
chr6
85650491
85678932
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.